Folgen
-
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily M. Godfrey, MD, MPH
A recent study presented at the 2023 ACOG Annual Clinical and Scientific Meeting examined patient perspectives on clinician communication regarding medication abortion during telemedicine versus in-clinic visits and found that patients prefer to receive abortion care via telemedicine. Learn more about the study’s design and results with Dr. Charles Turck and Dr. Emily Godfrey, Professor of Family Medicine and Obstetrics and Gynecology at the University of Washington.
-
Guest: Mitchell D. Creinin, MD
Dive into the research presented at the 2023 ACOG Annual Scientific and Clinical Meeting that found that the use of levonorgestrel 52-mg intrauterine device (IUD) in patients with heavy menstrual bleeding reduced blood loss by more than 90 percent over six months with Dr. Mitch Creinin, Professor in the Department of Obstetrics and Gynecology as well as the Director of the Complex Family Planning Fellowship at the University of California Davis Health.
-
Fehlende Folgen?
-
Guest: Mitchell D. Creinin, MD
While the use of levonorgestrel 52-mg intrauterine device (IUD) has been shown to reduce blood loss in patients with heavy menstrual bleeding, these same patients are at an increased likelihood of expelling the IUD. That’s why it’s important to set realistic expectations with patients, as Dr. Mitch Creinin from the University of California Davis Health explains.
-
Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG
Host: Charles Turck, PharmD, BCPS, BCCCP
New guidelines regarding the screening, diagnosis, and pharmacological treatment of perinatal mental health conditions as well as resources like in-depth toolkits and implementation guides are now available to help optimize the management of patients with perinatal mental health conditions. Find out how these tools can help you better address one of the most common complications of pregnancy with Dr. Charles Turck and Dr. Tiffany Moore Simas, the Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School who presented a few sessions focusing on this exact topic at the 2023 ACOG Annual Clinical and Scientific Meeting.
-
Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG
According to a poster that was featured at the 2023 ACOG Annual Clinical and Scientific Meeting, only 75 percent of patients at UMass Chan Medical School were screened for perinatal mental health conditions, and of those screened, white patients were more likely to be connected with appropriate care and treatment than black or Hispanic patients. Dive deeper into the findings that underscore the importance of addressing disparities and inequities in perinatal depression care with Dr. Tiffany Moore Simas, Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School.
-
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Roberto Romero, MD, DMedSci
Renowned international expert Dr. Roberto Romero joins Dr. Lee Shulman to walk us through maternal anti-fetal rejection. Find out about its pathophysiology, mechanisms of disease, approach to diagnosis, and potential treatment so that you can broaden your understanding and improve the care you provide.
-
Host: Jennifer Caudle, DO
Guest: Tamera A. Paczos, MD, FACOG, FACP
The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories.
COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 02/23 -
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Alexandra Benachi, MD, PhD
Guest: Julien Zuber, MD, PhD
Program Chairman:
Roberto Romero, MD, DMedSci
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and GynecologyThere exists a long-standing controversy about drawing parallels between transplant and pregnancy immunology. Listen in as Drs. Alexandra Benachi, Julien Zuber, and Lee Shulman discuss why these considerations are so important for you and your colleagues, patients, and their families to understand. Discover how links between kidney transplantation and maternal anti-fetal rejection may impact your practice and spark new pathways in medicine.
-
Host: Jennifer Caudle, DO
Guest: Diane M. Harper, MD, MPH, MS
There are several testing methods available for cervical cancer screening, such as co-testing and primary HPV testing. So what are some of the most prominent benefits and limitations of these and other testing approaches? Joining Dr. Jennifer Caudle to break down the latest advancements in cervical cancer screening is Dr. Diane Harper, a Professor in the Departments of Family Medicine and Obstetrics and Gynecology at the University of Michigan.
-
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Masja de Haas, MD, PhD
Program Chairman:
Roberto Romero, MD, DMedSci
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and GynecologyNeonatal alloimmune neutropenia (NAIN or NIN) is a neutrophil blood group antagonism similar to HDFN and FNAIT. Its presentation varies clinically and ranges from asymptomatic to severe manifestations such as sepsis and meningitis. Listen in as Drs. Masja de Haas and Lee Shulman discuss clinical clues that should catch your eye. Discover novel yet simple ways to be vigilant and make the right clinical calls.
-
HPV testing plays an important role in cervical cancer screening, but not every patient who's HPV-positive will develop cervical cancer. One option that can help us identify which HPV-positive patients are truly at risk is CINtec PLUS Cytology, an immunohistochemistry test that simultaneously detects p16 and Ki67 biomarker proteins. Learn more about how this dual staining technique works in this video.
-
Host: Andrea Singer, MD, FACP, CCD
Guest: Paul A. Anderson, MD
Guest: Susan V. Bukata, MD, FAOA, FAAOS
Since the recording of this CME activity, the following updates have been published:
NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women Menopause. 2021;28(9):973-997. Consensus Statement from the Bone Health and Osteoporosis Foundation, formerly known as the National Osteoporosis Foundation The Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis Int. 2022;33(10):2049-2102.While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.
-
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: James B. Bussel, MD
Program Chairman:
Roberto Romero, MD, DMedSci
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and GynecologyAs the platelet equivalent of hemolytic disease of the fetus and newborn, fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an uncommon yet complex and life-threatening bleeding disorder that results from incompatibility between mother and baby for platelet-specific antigens. Despite relatively normal platelet function, in the setting of severe thrombocytopenia, intracranial hemorrhage is a consequence. Drs. Shulman and Bussel discuss advances in management strategies and concrete steps you can take to lower the risk and stop the progression of this disorder in your patients.
-
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Linda Bradley, MD
Join Drs. Linda Bradley and Lee Shulman as they discuss factors contributing to disparities in care for patients with endometriosis and/or uterine fibroids. They offer practical tips to overcome the disproportionate disease burden that especially impacts women of color. Cut through the noise to clearly hear each patient’s voice. Your clinical impact may be profound.
-
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Kenneth J. Moise Jr., MD
Program Chairman:
Roberto Romero M.D. D.Med Sci.
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and GynecologyAre you taking the right steps to consistently ensure all of your patients at risk of alloimmune disorders of pregnancy, specifically HDFN, receive a helping hand plus timely and appropriate clinical care? Despite having considerable clinical consequences, this area of medicine is not fully understood by many clinicians. Drs. Shulman and Moise provide expert insight on red blood cell alloimmunization, highlighting essential pathophysiology and current and evolving management strategies. Join us to learn new ways to approach this complicated and rare clinical condition.
-
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Erica E. Marsh, MD, MSCI, FACOG
Hear from Dr. Erica Marsh and Dr. Lee Shulman as they discuss the burden, prevalence, and treatment of uterine fibroids and endometriosis and the disproportionate impact these conditions have on vulnerable populations. Learn how to prioritize early diagnosis and treatment to improve outcomes for your patients; as well as evaluating barriers to proper diagnosis and treatment
Our experts offer strategies to guide discussions beyond surgical treatment approaches to include pharmacotherapeutic options such as GnRH agonists and new oral GnRH antagonists. Open communication with patients allows them to carefully consider symptom severity, risks, and fertility preferences to optimize treatment outcomes and patient satisfaction. Tune in to make sure that you’re really doing all you can for your patients.
-
Host: Hector O. Chapa, MD, FACOG
Guest: Susan Crowe, MD
Both UNICEF and WHO recommend exclusive breastfeeding for the first six months of life, starting within the very first hour of birth. But are we adhering to that recommendation? Joining Dr. Hector Chapa to discuss the importance of breastfeeding shortly after delivery and how we can help our patients and their newborns reap the benefits of this golden hour is Dr. Susan Crowe, Director of Outpatient Breastfeeding Medicine Consultative Services at Stanford Children's Health who recently spoke about this topic at the 2021 ACOG Annual Clinical and Scientific Meeting.
-
Host: Ana Maria Rosario
Guest: Patricia M. Boatwright, MD
As any healthcare professional would agree, being passionate about your practice is key to having a good relationship with your patients. But choosing a specific specialty isn’t always an easy or clear decision. Joining Ana Maria Rosario to share how she came to her decision and a few experiences that made her into the healthcare professional she is today is Dr. Patricia Boatwright, an ob-gyn and Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine.
-
Guest: Patricia M. Boatwright, MD
Ob-gyn Dr. Patricia Boatwright once cared for a patient who told her the following philosophy: "If it doesn't bother you, don't bother it." Sadly, this is far from the only isolated event in which healthcare professionals hear this or a similar mantra from their patients. To help us better manage this all-too-common occurrence, Dr. Boatwright walks us through this particular patient case and how she encourages her patients to listen to their bodies rather than their peers.
-
Host: Ana Maria Rosario
Guest: Patricia M. Boatwright, MD
When a patient comes to an appointment saying, “I want” or “I need,” it can be difficult to challenge them. But as ob-gyn Dr. Patricia Boatwright explains, doing so is absolutely critical to ensuring they receive the best and most appropriate care. Tune in to hear Ana Maria Rosario and Dr. Boatwright discuss a patient case and how we can do right by our patients, even if it means challenging their—or even a colleague's—opinion.
- Mehr anzeigen
